The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients

A Algaba, PM Linares, Fernández-Contreras M Encarnación, A Figuerola, X Calvet, I Guerra, Pousa I de, M Chaparro, JP Gisbert, F Bermejo

Research output: Contribution to journalArticleResearch

14 Citations (Scopus)
Original languageEnglish
Pages (from-to)695-702
JournalInflamm Bowel Dis
Volume20
Publication statusPublished - 1 Jan 2014

Cite this